Despite these strong financial results, the company's shares declined by approximately 3.4% in premarket trading on Tuesday. For the quarter, the company's medical loss ratio, which measures the percentage of premiums spent on medical care, was 85.2%. This figure is higher than both the 82.3% reported in the same quarter the previous year and the analysts' estimate of 84.2%.
103356238jenny tan :
103356238jenny tan :